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PROSES PEMAKANAN Plasmodium falciparum DALAM ERITROSIT YANG 
MENGANDUNGI PENANDA ENDOSITIK DAN PERANANNYA 
TERHADAP TINDAKAN ARTEMISININ 
 
ABSTRAK 
 
Metabolisme hemoglobin pada peringkat intraeritrosit parasit malaria, 
Plasmodium falciparum adalah sasaran utama artemisinin yang digunakan secara 
meluas dalam rawatan dan kawalan penyakit malaria. Kajian sebelum ini melaporkan 
bahawa parasit mengambil hemoglobin melalui struktur seperti mulut yang 
dinamakan sebagai sitostom. Vesikel yang mengandungi hemoglobin berputik keluar 
dari sitostom dan diangkut ke vakuol pencernaan (DV) untuk dicerna. Walau 
bagaimanapun, perincian mengenai proses endositik serta bagaimana artemisinin 
memberi kesan terhadap proses ini masih diperdebat. Oleh itu, dalam kajian ini 
proses pengambilan hemoglobin oleh parasit dan kesan artemisinin terhadap proses 
ini telah dikaji semula dengan menggunakan penanda endositik, 
tetramethylrhodamine-dextran (TMR-dextran) dan indikator pH, Lysosensor Blue 
(LB) dan SNARF-1-dextran. Penyediaan eritrosit yang mengandungi TMR-dextran 
telah dilakukan menggunakan nisbah optimum 1 isipadu eritrosit kepada 3 isipadu 
penimbal hemolisis. Eritrosit yang mengandungi TMR-dextran ini mengekalkan 
33.56 ± 7.84% kandungan hemoglobin asal dan menunjukkan kadar infeksi parasit 
yang setanding dengan eritrosit normal. Dalam eritrosit yang mengandungi TMR-
dextran ini, proses endositik parasit bermula pada peringkat muda (bentuk cincin 
pertengahan) dengan kehadiran struktur endositik kecil yang tipikal dan struktur 
sfera besar yang dinamakan sebagai "big gulp". DV kelihatan pada peringkat akhir 
 xviii 
 
trofozoit dan skizon. Struktur DV kelihatan padat dengan TMR-dextran dan 
berkeadaan berasid kerana telah dilabel oleh LB. Rawatan artemisinin menunjukkan 
tiada kesan terhadap proses pengambilan hemoglobin oleh parasit and tiada 
perubahan pada penglabelan LB dan SNARF-1-dextran pada DV yang menunjukkan 
tiada perubahan pH yang ketara pada vakuol tersebut. Kesimpulannya, hemoglobin 
diambil oleh parasit pada peringkat awal intraeritrosit dan dikumpul di dalam DV 
yang berasid di mana vakuol ini tidak menunjukkan perubahan pH yang signifikan 
kepada rawatan artemisinin.  
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THE FEEDING PROCESS OF Plasmodium falciparum IN RESEALED 
ERYTHROCYTES CONTAINING ENDOCYTIC MARKERS AND ITS 
ROLE IN ARTEMISININ ACTION 
 
ABSTRACT 
 
Haemoglobin metabolism during the intraerythrocytic stage of the 
malaria parasite, Plasmodium falciparum is a preferable target for artemisinin, which 
is widely used for treatment and control of malaria. It has previously been reported 
that the parasite ingests haemoglobin via mouth-like structures named cytostomes.  
Haemoglobin-containing vesicles that bud off from cytostomes are transported to the 
digestive vacuole (DV) where the haemoglobin is degraded. However, the details of 
endocytic process as well as how artemisinin affects this process are still debatable. 
Hence, in this study we re-examined the endocytic process of the parasite and 
observed the effect of artemisinin on this process by using an endocytic marker, 
tetramethylrhodamine-dextran (TMR-dextran) and a pH indicator, Lysosensor Blue 
(LB) and SNARF-1-dextran. Resealed erythrocytes containing TMR-dextran were 
prepared at an optimised ratio of 1:3 of erythrocytes to haemolysis buffer volume. 
The resealed erythrocytes permitted retention of 33.56 ± 7.84% of the original 
haemoglobin contents and showed comparable parasite‟s invasion efficiency to 
normal erythrocytes. An early endocytic event of the parasites was initiated at mid 
ring stage with appearance of typical small endocytic compartments and a large 
spherical structure termed as a “big gulp”. An acidic DV concentrated with TMR-
dextran and labelled with LB, appeared at the later stages of trophozoite and 
schizont. Artemisinin treatments on this process showed no modification on the 
 xx 
 
haemoglobin intake by the parasite and no alterations of the LB label and SNARF-1-
dextran of the DV indicating no major pH changes of the vacuole. In conclusion, 
haemoglobin is ingested by the parasite at early intraerythrocytic stage and 
accumulated in the acidic DV where the vacuole showed no significant pH 
alterations upon the artemisinin treatments.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background of the study 
 
Malaria is one of the most severe public health problems in poor and 
developing countries worldwide. In 2015, approximately 212 million people were 
infected with malaria, which resulted in 429 000 deaths (World Health Organization 
(WHO), 2016a). In Malaysia, malaria cases and deaths declined about 51% and 89%, 
respectively, from 2014 to 2015 (WHO, 2016a). Despite the declining cases, malaria 
is still one of the major public health problems in Malaysia since there are frequent 
travels and influxes of foreign workers from malaria-endemic countries that may 
spread the infection to local people (Vector Borne Disease Sector Ministry of Health, 
2014). 
 
There are 91 countries with ongoing malaria transmission, including 
Malaysia, where there were 3.2 billion people at risk of the infection in 2015 (WHO, 
2016b). The transmission of malaria is mostly by Anopheles mosquitoes as a vector 
and rarely by blood transfusion, needle stick injury and congenital malaria. An 
infected mosquito transmits Plasmodium sporozoites, an infectious stage of the 
parasite, to a healthy individual during the blood meal. There are more than 100 
species of Plasmodium that can cause malaria and only five species are related to 
humans including P. falciparum, P. vivax, P. ovale, P. malariae and P. knowlesi 
(Lim et al., 2013). Of these, P. falciparum causes the most severe malaria infection 
and deaths globally (Centers for Disease Control and Prevention (CDC), 2016a). 
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P. falciparum requires two hosts to complete its life cycle, a female 
Anopheles mosquito as a definitive host and a human as an intermediate host. In 
humans, there are two cycles involved: the exoerythrocytic cycle in liver cells and 
the intraerythrocytic cycle in erythrocytes (Warrell & Gilles, 2002). Most of the 
clinical malarial symptoms are resulted from repeated intraerythrocytic cycle in 
erythrocytes. It usually follows with the episode of fever, shivering and sweating, 
and may lead to organ failures or death if not treated promptly (Miller et al., 2013). 
To reduce malarial cases and avoid deaths, early diagnosis and treatment are 
essential either in uncomplicated or complicated malaria. Up until recently, the best 
treatment for malarial infection is by using artemisinin-based combination therapies 
(ACTs) (WHO, 2015a). 
 
The combination of artemisinin and other drugs has made ACTs a 
current first-line treatment for P. falciparum infections that greatly controls malaria. 
Nevertheless, the urge in developing new antimalarial drugs is crucial due to the 
emergence of parasite resistance towards available drugs (Kalra et al., 2006). 
Moreover, the resistance to artemisinin and its derivatives has been reported in 
Southeast Asia countries such as in Cambodia, Laos, Myanmar, Thailand and 
Vietnam (Petersen et al.,  2011). In between the 1950s and 1960s, P. falciparum 
started to develop resistance towards a well-known antimalarial drug, chloroquine 
(CDC, 2015). Since then, P. falciparum has continued to develop resistance towards 
other antimalarial drugs such as sulphadoxine, mefloquine, halofantrine, quinine, and 
the most worryingly to artemisinin. The persistent threat of resistance urges the 
search and development of new potent antimalarial drugs as alternatives for 
treatment against the disease.  
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Most antimalarial drugs available have targeted various parasite stages in 
the exoerythrocytic and intraerythrocytic cycles. The intraerythrocytic stage of the 
parasite is the preferable target in developing new drugs as it is responsible for 
clinical malarial symptoms and illness. The elimination of blood stage parasites after 
treatment normally has caused rapid clinical improvement (Schlesinger et al., 1988). 
The frontline drugs that specifically interfere with haemoglobin metabolism of the 
parasite are the drugs of choice to treat the disease (Miller et al., 2013). Thus, 
investigation of the biological aspects of P. falciparum in the host erythrocyte, such 
as details on haemoglobin metabolism, is crucial to shed light into the development 
of effective yet long lasting new antimalarial drugs.  
 
1.2 Rationale of the study 
 
P. falciparum is thought to feed on haemoglobin via cytostome-
dependent endocytosis (Francis et al., 1997). Cytostomes pinch off at the neck and 
form double-membrane haemoglobin-filled vesicles, which are transported to and 
fused with a central digestive vacuole of the parasite (Aikawa, 1966; Slomianny, 
1990). The haemoglobin is also thought to be digested en route to the digestive 
vacuole (Abu Bakar et al., 2010). A previous study suggested the involvement of 
several endocytic pathways termed as the “big gulp”, cytostomal tube and vesicle, 
and phagosome (Elliott et al., 2008). Another finding revealed a conversely different 
model of haemoglobin transport via a vesicle-independent process (Lazarus et al., 
2008). In the process, small cytostomes extended into longer structures and fused 
with the digestive vacuole to release ingested haemoglobin into the digestive 
vacuole‟s lumen.  
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The precise mechanism of haemoglobin uptake by the malaria parasite is 
still debated despite the potential of haemoglobin metabolism as a target for new 
antimalarial drugs and treatment strategies. For instance, obstruction of haemoglobin 
digestion and haem detoxification or any process in haemoglobin metabolism would 
be fatal to the parasite (Olliaro & Yuthavong, 1999). Improved understanding of the 
mechanism of action of artemisinin is important, which helps the development of 
novel treatment strategies to combat resistance towards the drug. Thus, re-
examination of haemoglobin uptake and transport, and the effect artemisinin has on 
these pathways could shed light into the possible mechanism of artemisinin action 
and resistance, rational design of new potent endoperoxide antimalarial drugs and 
development of novel treatment strategies.  
 
To observe parasite ultrastructures involved in haemoglobin uptake and 
transport, most researchers have relied on serial thin-section electron microscopy. 
This technique might introduce artefacts due to sectioning process of blood cells into 
70 nm thick as compared to the average size of intraerythrocytic parasites (~5 µm in 
diameter) (Milani et al., 2015). While observation of direct stained cells under light 
microscope often contributes to deposit of artefacts (Wilson & Bacic, 2012), which 
can cause disturbances during the analysis and even produce false positive results. In 
this present study, the parasite feeding process and the effect artemisinin has on this 
process were re-examined by using live cell fluorescence microscopy. Using resealed 
erythrocytes containing fluorescent probes, indicators of the endocytic process or pH 
of the endocytic structures, provided a better observation for monitoring dynamic 
cellular processes in physiological conditions.  
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1.3 Objectives of the study 
 
1.3.1 General objective  
 
To investigate malaria parasite‟s endocytic processes and structures, which feed the 
digestive vacuole and their role in artemisinin action. 
 
1.3.2 Specific objectives  
 
1. To optimise the resealing method for preparation of resealed erythrocytes 
containing fluorescent probes. 
2. To inoculate resealed erythrocytes containing fluorescent probes with 
malaria parasites. 
3. To observe haemoglobin uptake and transport in malaria parasite-
infected erythrocytes containing fluorescent probes. 
4. To determine the sensitivity of artemisinin against different 
intraerythrocytic stages of parasite development. 
5. To investigate the effect of artemisinin on haemoglobin uptake by the 
parasite. 
6. To determine the effect of artemisinin on pH of the endocytic structures 
and digestive vacuole. 
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1.4 Experimental design  
 
In this study, the feeding process of the malaria parasite and the effect of 
artemisinin on haemoglobin uptake and pH of endocytic structures were investigated. 
The studies were carried out based on the framework as illustrated in Figure 1.1 
using endocytic fluorescent markers, which were high molecular weight dextran-
conjugated tetramethylrhodamine-dextran (TMR-dextran) and 5‟(and 6‟)-carboxy-
10-dimethylamino-3-hydroxy-spiro[7H-benzo[c] xanthene-7,1‟(3H)-isobenzofuran]-
3‟-one dextran (SNARF-1-dextran), and a pH fluorescent indicator, which was 
Lysosensor Blue. To incorporate these high molecular weight dextran conjugates into 
erythrocytes, the resealing technique was optimised. Resealed erythrocytes 
containing TMR-dextran or SNARF-1-dextran were prepared using an optimised 
ratio of erythrocytes to haemolysis buffer volume before being inoculated with 
mature stage parasites. Determination of the optimum ratio of erythrocytes to 
haemolysis buffer volume was carried out to achieve a homogenous distribution of 
the probe while minimising loss of haemoglobin. Resealed erythrocytes were 
investigated in terms of their ability to support parasite growth. The parasites were 
synchronised at their ring stage and harvested after 24 hours post-synchronisation. 
Resealed erythrocytes were inoculated with harvested mature stage parasites, and 
haemoglobin uptake and transport were monitored throughout the 48 hours life cycle 
by fluorescence microscopy.  
 
To evaluate the effect of artemisinin on the parasite‟s feeding process, 
the inhibition concentration of artemisinin towards 50% of the parasite population 
was initially identified. The inhibition concentration obtained was used as a reference 
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concentration in a subsequent experiment of the sensitivity of artemisinin in different 
intraerythrocytic stages of the parasite, which was evaluated by fluorescence-based 
assays, whereas morphological changes were observed by Giemsa-stained thin blood 
smears. The effect of artemisinin on the haemoglobin uptake was examined in 
parasite-infected erythrocytes containing TMR-dextran using a drug short pulse (4 
hours) mimicking clinical exposure of artemisinin (~3–4 hours). The pH alteration of 
the endocytic structures and digestive vacuole upon 4-hours artemisinin treatment 
was also observed.  
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Investigation of the drug sensitivity on different stages of the 
malaria parasite 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Flowchart of the experiments carried out during the study 
The parasite culture was established in line with the production of resealed 
erythrocytes entrapped with TMR-dextran. Once the parasite cultures were stabilised, 
optimised resealed erythrocytes were inoculated with mature stages parasites. An 
early event of the haemoglobin uptake by P. falciparum was monitored by 
fluorescence microscope. The effects of artemisinin against different stages of the 
parasite, the feeding process and the pH of digestive vacuole were investigated. 
In vitro culture of the parasites  Preparation of  
resealed erythrocytes 
Synchronisation of ring stage parasite- 
infected erythrocytes 
Measurement of haemoglobin loss 
and retained in resealed erythrocytes 
Purification of mature stage  
parasite-infected erythrocytes 
Preparation of resealed erythrocytes  
containing fluorescent probes 
Inoculation of mature stage parasites  
with resealed erythrocytes 
Investigation of the feeding process of the  
malaria parasite 
Determination of 50% inhibitory concentration of artemisinin  
Investigation of the effect of artemisinin on pH 
of the digestive vacuole 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Malaria overview 
 
Malaria is an ancient disease affecting humans and one of the most 
devastating public health problems (Cox, 2010). The disease is caused by protozoan 
parasites of the genus Plasmodium, which are transmitted by female Anopheles 
mosquitoes during a blood meal (Miller et al., 2013). In the early stage of infection, 
patients will experience fever, chills, abdominal discomfort and vomiting. Without 
prompt treatment, the infection will cause more severe conditions such as anaemia, 
renal failure, coma and even death (Haldar et al., 2007).  
 
2.1.1 Worldwide distribution of malaria 
 
Globally, there were 212 million malaria cases and 429 000 malaria 
deaths reported in 2015 (WHO, 2016a). Although malaria cases and deaths reduced 
to 37% and 60%, respectively, from 2000–2015, it is estimated that more than 3.2 
billion people are still at risk of malaria in 91 countries and territories with ongoing 
malaria transmission (WHO, 2016a). Most of the western countries, particularly the 
developed countries, have successfully eliminated the disease (Figure 2.1), but 
several low-income and developing countries in America and Southeast Asia are still 
facing the ongoing malaria transmission. The African region remains as an endemic 
malaria area, which was home to 90% of malaria cases and 92% of malaria deaths in 
2015. Although significant reduction of malaria cases and deaths was reported  
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Figure 2.1: The malaria incidence rates worldwide from 2000-2015 
Most of the countries in America and Europe are free from malaria with exception of Venezuela. Other regions such as in Southeast Asia are still 
facing the active transmission of malaria with a high percentage of incidence rates. Modified from WHO (2016a).  
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globally, but the slowest reduction rate was recorded in the African region (Cibulskis 
et al., 2016). This has become a challenge for other countries to achieve or maintain 
a malaria-free status, including Malaysia, which has aimed for the status in 2020.  
 
2.1.2 Epidemiology of malaria in Malaysia 
 
In Malaysia, malaria cases were detected even before 1990. In 1990, 
about 50 500 malaria cases and 43 malaria deaths were reported (Vector Borne 
Disease Sector Ministry of Health, 2014). With aggressive prevention and control 
measures, the numbers decreased to 12 705 cases and 35 deaths in 2000. However, 
from 2006–2008, an increasing pattern of malaria cases was observed (Figure 2.2). 
Since then, a decreasing trend of malaria cases was seen from 2008-2015 (WHO, 
2016a). The decreasing trend of malaria cases as well as malaria deaths in Malaysia 
has indicated a good sign towards the national progress and target for elimination of 
malaria in 2020.  
 
Out of five Plasmodium species that can infect humans, P. vivax caused 
the most of malaria cases in Malaysia from 2010-2014, followed by P. falciparum 
and other species (WHO, 2016a). However, P. vivax cases were declined and P. 
falciparum leaded the malaria cases in Malaysia that accounted for 132 cases out of 
242 cases in 2015 (WHO, 2016a). In addition to this, there was an emergence of P. 
knowlesi cases that were reported especially in Sabah and Sarawak from the year 
2004 (William et al., 2013). 
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Figure 2.2: The number of malaria cases in Malaysia from 2005-2015 
The total numbers of malaria cases in Malaysia were decreased from 2005-2007. In 2008, the cases were increased, but decreased in the 
following years until 2013.  Modified from World Malaria Report (2016a).  
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2.2 Human malaria parasites and their transmission  
 
The causative agents of malaria are protozoan parasites of the genus 
Plasmodium. Plasmodium is a member of the family Plasmodiidae, order 
Haemosporida and phylum Apicomplexa (Martinsen & Perkins, 2013). There are 
over 200 Plasmodium species under the sub-genus of Laverania (higher primates as 
hosts), Vinckeia (non-primate mammals as hosts) and Plasmodium (higher primates 
and humans as hosts) (see details in Table 2.1) (Warrell & Gilles, 2002). 
Plasmodium species that can infect humans are P. falciparum, P. vivax, P. ovale, P. 
malariae and P. knowlesi. P. falciparum possesses a great threat especially in 
endemic countries causing a majority of morbidity and mortality (Guinovart et al., 
2006).  
 
P. vivax is considered the second most prevalent species as it has a wide 
distribution and is prevalent outside of Africa especially in Southeast Asia and 
Western Pacific region (Howes et al., 2016). The distribution of P. malariae 
generally coincides with that of P. falciparum in areas of endemicity in Africa. In 
many instances, the presence of P. malariae infections is unapparent unless 
polymerase chain reaction (PCR) techniques are used to reveal low level infections. 
P. knowlesi is known to cause zoonotic malaria in humans since the first case 
reported in the United States in 1965. Since then, no cases were reported until 2004 
when significant P. knowlesi infections were reported in Sarawak (Kantele & 
Jokiranta, 2011). 
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Table 2.1: Plasmodium species under the sub-genus of Plasmodium, 
Laverania and Vinckeia 
 
Sub-genus Species 
Plasmodium P. vivax, P. cynomolgi, P. eylesi, P. gonderi, P. hylobati,  
P. jefferyi, P. pitheci, P. schwetzi, P. simium, P. sylvaticum,  
P. youngi, P. ovale, P. fieldi, P. simiovale, P. malariae,  
P. brazillianum, P. inui, P. coatneyi, P. fragile and  
P. knowlesi.   
Laverania P. falciparum and P. reichenowi.  
Vinckeia P. berghei, P. cyclopsi, P. traguli, P watteni, P. vassal, P. 
yoelii and other large number of species that mainly infect 
lemurs, rodents, bats and other animals.   
 
Over 200 species of Plasmodium are divided into 3 sub-genera: Plasmodium, 
Laverania and Vinckeia. Adapted from Warrell & Gilles (2002). 
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Malaria can be transmitted through blood transfusion, organ transplant 
and shared use of needles contaminated with infected blood (National Institute of 
Allergy and Infectious Disease, 2009). The infection can be passed from mother to 
baby during pregnancy or delivery causing congenital malaria. The disease is usually 
transmitted to humans via the bite of an infected female Anopheles mosquito during a 
blood meal. The mosquito acts as a vector during transmission and a reservoir for 
completing the sexual phase of the parasite‟s life cycle as illustrated in Figure 2.3.  
 
In humans, the malaria parasite begins its life cycle in the host hepatocyte 
where it multiplies and differentiates into a schizont containing thousands of hepatic 
merozoites. After the hepatocyte ruptures, the merozoites subsequently invade the 
erythrocytes where they grow and replicate into schizonts. The schizonts then rupture 
releasing erythrocytic merozoites and this cycle produces more merozoites after 
repeated rupturing of the erythrocytes, which is responsible for the prodromal 
symptoms attributable to the disease. In the early stage of infection, the symptoms 
are usually nonspecific and mimic flu-like syndrome such as fever, chills, headaches 
and diaphoresis (Bartoloni & Zammarchi, 2012). 
 
After a few weeks, the fever will be periodic with an increase in 
prodromal symptoms such as anorexia, nausea, vomiting and diarrhoea. Without 
accurate diagnosis and immediate treatment, the uncomplicated symptoms may lead 
to severe malaria. In severe malaria cases caused by P. falciparum, systems affected 
include central nervous system (CNS), pulmonary system, renal system and 
haematopoietic system (Trampuz et al., 2003), which lead to severe complications  
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Figure 2.3: The transmission of malaria 
(a) A female Anopheles mosquito is not infectious until it bites a malaria parasite-
infected human during a blood meal. (b) During a blood meal, parasites in the form 
of gametocytes are transferred (c) and developed sexually in the mosquito. (d) The 
infected mosquito transmits parasites in the form of sporozoites to a healthy human 
during its next blood meal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
  
 
 
 
 
 
 
 
 
 
   
a) Uninfected      
mosquito 
b)   Uninfected 
mosquito bites an 
infected human 
c)   The mosquito 
becomes infected 
after the previous 
blood meal 
d)   The infected 
mosquito transmits 
the parasites to a 
healthy human 
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such as cerebral malaria, pulmonary oedema, acute renal failure, severe anaemia, 
acidosis and hypoglycaemia. Without prompt diagnosis and appropriate treatment, 
the complications can progress rapidly and worsen to death (English & Newton, 
2002). 
 
2.2.1 Life cycle of the human malaria parasite 
 
The malaria parasite requires two hosts to complete its life cycle 
comprising a sexual phase occurring in a female Anopheles mosquito (a definitive 
host) and an asexual phase occurring in a human (an intermediate host). There is, 
thus, an alternation of generation and hosts in the parasite‟s life cycle.  
 
2.2.1(a) Sexual phase within a mosquito  
 
A female Anopheles mosquito takes a human blood meal on a regular 
basis as the source of nutrients for batches of eggs to develop (Mamai et al., 2017). 
Once ingested, certain forms of blood stage parasites called gametocytes travel to the 
mosquito‟s midgut where the development of the parasites begins (Figure 2.4). The 
male and female gametocytes develop and fuse to form zygotes. Approximately 18–
24 hours after the blood meal, the zygotes develop into ookinetes. Ookinetes invade 
stomach epithelial cells and reside in the cells‟ cytoplasm. Fractions of the ookinetes 
emerge through the midgut basal plasma membrane and differentiate. The infected 
mosquito inoculates the sporozoites into the human host. 
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Figure 2.4: The life cycle of the malaria parasite within a mosquito 
The parasites in the form of gametocytes are taken into the midgut of the mosquito. 
The fertilisation of male and female microgametocytes occurs to form a zygote. 
Within 18-24 hours, the zygote develops into an ookinete, which then transforms into 
an oocyst. After 10-24 days, thousands of sporozoites are released into the 
haemocoel and invade the salivary gland epithelium Modified from CDC (2016b). 
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During a blood meal, the differentiation of ookinetes causes cell 
segmentation and increase in size producing oocysts (Smith et al., 2014). The 
cytoplasm of the oocysts starts to divide into sections called sporoblasts. The 
sporoblasts start to develop producing sporozoites. The formation of many 
sporozoites weakens the oocyst wall and eventually causes the release of sporozoites 
through the cell wall and basal lamina to enter the haemocoel cavity of the mosquito 
(Warrell & Gilles, 2002).  
 
2.2.1(b) Asexual phase within a human host 
 
Sporozoites in the salivary gland of an infected mosquito are readily 
injected into human capillaries during a blood meal (Figure 2.5) (Aly et al., 2009). 
Shortly after the inoculation (~2 minutes), the parasites reach the liver and invade the 
hepatocytes initiating the exoerythrocytic schizogony. The parasite enlarges in size 
and undergoes repeated nuclear division. The cytoplasm surrounds each daughter 
nucleus. This stage of parasite is called the schizont containing thousands of hepatic 
merozoites. After 8 days of incubation, mature schizonts burst and liberate 
merozoites (Fujioka & Aikawa, 2002). Some sporozoites of P. vivax and P. ovale, on 
entering hepatocytes, become rounded and remain dormant (Hulden & Hulden, 2011; 
Richter et al., 2016). This stage of parasite is called the hypnozoite. The hypnozoite 
activates from time to time to become a merozoite-containing schizont.  
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Figure 2.5: The development of the malaria parasite in a human host 
Once inoculated, the parasites in the form of sporozoites enter the liver cells. In the 
liver cells, they develop into schizonts. Once matured, the schizonts rupture and 
merozoites are released into the blood circulation. The merozoites invade the 
erythrocytes and develop into ring, trophozoite and schizont. The matured schizonts 
rupture and release merozoites. The merozoites invade new fresh erythrocytes. Some 
of newly invaded merozoites differentiate into gametocytes. Modified from CDC, 
(2016b). 
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Released merozoites invade the erythrocytes to initiate the 
intraerythrocytic schizogony. The parasite enters the erythrocyte by endocytosis 
(Chamberlain, 2014). The parasite cytoplasm enlarges in the erythrocyte to form an 
ovoid structure with a point-rounded nucleus, which makes the parasite looks like a 
ring structure (Figure 2.6A) (Bannister et al., 2000). As the nucleus and cytoplasm of 
the parasite enlarge, the parasite called as a trophozoite in which the structure 
becomes spherical and the nucleus turns into an irregular shape (Figure 2.6B). The 
end of the trophozoite stage is manifested by multiple nuclear divisions within the 
parasite to form a schizont (Bannister et al., 2000). The nucleus first divides into 
several small nuclei, while cytoplasm remains undivided. This parasite is called an 
early schizont (Figure 2.6C).  
 
 When each daughter nucleus becomes surrounded by the cytoplasm 
(forming merozoites), this parasite is called a late schizont (Glushakova et al., 2005). 
This schizont ruptures and releases merozoites into the blood circulation (Fujioka & 
Aikawa, 2002). The merozoites invade fresh erythrocytes in which they go through 
the same development process. After many cycles of the intraerythrocytic 
schizogony, some merozoites do not form schizonts, but develop into sexually 
differentiated gametocytes that will ensure parasite transmission to the mosquito. 
During this stage, the parasites rely on the amino acids from host haemoglobin to 
support their growth and maturation. These amino acids are derived from the 
haemoglobin through a process known as haemoglobin metabolism.  
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Figure 2.6: The three-dimensional morphology of malaria parasite during intraerythrocytic stage 
(A) After invasion, malaria parasites develop into ring stage (early, mid and large rings), (B) follows with trophozoite (early, mid and late 
trophozoites) and (C) schizont stages (early and late schizonts). Modified from Bannister et al. (2000). 
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2.3 Haemoglobin metabolism of P. falciparum   
 
Within the erythrocyte, the parasite is in a conclusive environment 
surrounded by high content of haemoglobin (340 mg/mL concentration) (Branden & 
Tooze, 1999). This protein comprises 95% of the soluble erythrocyte protein (Roux-
Dalvai et al., 2008). About 25%–75% of the haemoglobin are proposed to be 
degraded into haem and globin during the intraerythrocytic parasite development 
(Goldberg et al., 1990). The globin is used as a source of essential amino acids since 
the parasite lacks the ability to renew amino acid synthesis or to take them 
exogenously. Meanwhile the toxic inert polymer of haem is coordinated into a 
crystalline non-toxic form called haemozoin or malaria pigment (Goldberg, 1993). 
Generally, the parasite‟s haemoglobin metabolism consists of several pathways such 
as haemoglobin ingestion, haemoglobin degradation and haem detoxification. These 
pathways must be coordinated in a highly efficient manner by the parasite.   
   
2.3.1 Haemoglobin ingestion 
 
Haemoglobin ingestion is thought to begin at the early stage of parasite 
development by micropinocytosis (Rudzinska et al., 1965; Slomianny, 1990). A 
small portion of haemoglobin is internalised into the parasite by invagination (Milani 
et al., 2015). The invagination of both parasitophorous vacuolar membrane (PVM) 
and parasite plasma membrane (PPM) is mediated by a structure known as 
cytostome, which endocytoses the haemoglobin into the parasite. At the 
morphological level, the cytostome is defined as a large pear-shaped structure with 
enclosed double membranes and the presence of electron-dense material at the 
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cytostome neck (Langreth et al., 1978; Vaid et al., 2010). The cytostome pinches off 
forming haemoglobin-containing vesicles surrounded by two membranes: the outer 
membrane is derived from the PPM and the inner membrane is derived from the 
PVM. The vesicles are thought to be transported to an acidic vacuole, known as the 
digestive vacuole (Yayon et al., 1984; Slomianny, 1990). The outer membrane of the 
vesicles fuses with the outer membrane of the digestive vacuole releasing a single 
membrane vesicle inside the vacuole lumen.  
 
A study by Elliot et al. (2008) proposed four distinct pathways of 
haemoglobin uptake at the early ring stage of the parasite. These four pathways 
included the formation of the “big gulp”, cytostome-derived vesicles and tubules, and 
phagotrophs. The “big gulp” was described as a large lysosomal compartment of the 
parasite filled with haemoglobin. As shown in Figure 2.7A–C, the “big gulp” 
formation started right after the invasion into the erythrocyte in which the parasite 
flattens out and forms a biconcave shape. Both ends of the parasite slowly formed a 
cup shape and fused to form a large single vacuole. These authors showed that as the 
parasite matures, the haemoglobin ingestion process continued by small cytostome-
derived haemoglobin-containing vesicles and tubules. The ingestion of haemoglobin 
via a long double membrane-bound tubular invagination was consistent with a 
finding by Slomianny (1990). The formation of phagotrophs was similar to the “big 
gulp” appearance in terms of actin independent, but appeared multiple times at late 
trophozoite and schizont stages compared to the “big gulp”, which occurred once at 
the ring stage.   
 
 
 
